The epigenetics market, valued as a USD 4.38 billion market in 2016, is expected to become a USD 14.32 billion market by 2021, showing a CAGR as high as 26.72%.
Epigenetics is the study of changes in gene expression caused by certain base pairs in DNA, or RNA, being "turned off" or "turned on" again, through chemical reactions. In biology, and specifically genetics, epigenetics is mostly the study of heritable changes that are not caused by changes in the DNA sequence; to a lesser extent, epigenetics also describes the study of stable, long-term alterations in the transcriptional potential of a cell that are not necessarily heritable.
The term also refers to the changes themselves- functionally relevant changes to the genome that do not involve a change in the nucleotide sequence. Examples of mechanisms that produce such changes are DNA methylation and histone modification, each of which alters how genes are expressed without altering the underlying DNA sequence.
Global Epigenetics Market for Therapeutics, Research & Development- Market Dynamics
The report lists several driving and restraining factors of the global epigenetics market. Some of them are listed below.
The epigenetics market is segmented on the basis of mechanism, applications, and geography. The mechanism sector can be segmented into three different categories namely DNA Methylation, RNA Interference and Histone Modifications. The application segment can again be divided into categories such as Therapeutics and Research & Diagnostics. On the basis of geography, the market is divided into North America, Europe, APAC and the Rest of the World.
Some of the key players in the market are:
Key Deliverables in the Study